Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ASTRAZENECA PHARMACEUTICALS LP
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-09-30 to 2022-09-30
Current total value of award: $1107968000
Description: THE PURPOSE OF THIS MODIFICATION IS TO UP THE POINT OF ACCEPTANCE FOR 50K DOSES.